Postmenopausal women may have a new advantage in weight management.
The study indicates a 35% greater weight loss with combined therapies.
Tirzepatide is an obesity drug that shows promising results.
Postmenopausal women may have a new advantage in weight management.
The study indicates a 35% greater weight loss with combined therapies.
Tirzepatide is an obesity drug that shows promising results.